GLIPR1 and neoplasm: There was a trend towards reduced tumour burden at 4 weeks in the KaLwRij mice inoculated with 5TGM1-Glipr1 cells compared with those mice inoculated with 5TGM1-EV cells, but this decrease did not reach statistical significance (P = 0.246; Fig 4A).